ReviewCytotherapy2014

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.

Francesco Saglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.